Notably, type I IFN, namely IFN-β, has previously been reported to inhibit spontaneous release of IL-22 from otherwise unstimulated CD4+ T cells obtained from multiple sclerosis patients 17. The gene discussed is IL22; the disease is multiple sclerosis.